Literature DB >> 6970814

Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis.

H Lom-Orta, D Alarcon-Segovia, E Diaz-Jouanen.   

Abstract

We compared 31 patients who did, and 31 patients who did not, fulfill 4 or more criteria for the classification of systemic lupus erythematosus (SLE) at the time of diagnosis. Twenty-one of the latter 31 patients eventually developed enough manifestations to fulfill classification criteria. Ten never did despite average follow-up of 41 months. Patients who did not fulfill criteria at the time of diagnosis frequently had more thrombocytopenia and/or hemolytic anemia and continued to have fewer manifestations during the course of their disease than those who did. Failure to include this subject of SLE in studies with series of SLE patients may give a distorted picture of the disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6970814

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Beta 2-microglobulin and its binding activity in serum from patients with SLE.

Authors:  P E Evrin; T Ström
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

2.  Testing clinical criteria for systemic lupus erythematosus in other connective tissue disorders.

Authors:  P L Tan; G B Borman; R D Wigley
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

3.  Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.

Authors:  A Elisabeth Hak; Elizabeth W Karlson; Diane Feskanich; Meir J Stampfer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-10-15

4.  An unusual case of loin pain and nephritis.

Authors:  Alison Lap-tak Ma; Wai-ming Lai; Man-chun Chiu
Journal:  Clin Exp Nephrol       Date:  2009-10-03       Impact factor: 2.801

5.  Changes in clinical features of patients with systemic lupus erythematosus followed prospectively over 2 decades.

Authors:  A J Swaak; E J Nieuwenhuis; R J Smeenk
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.